Tokyo, Japan

Akira Ishiguro

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Akira Ishiguro: Innovator in Cell Penetrating Peptides

Introduction

Akira Ishiguro is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of cell penetrating peptides. With a total of five patents to his name, Ishiguro's work has the potential to impact various applications in medicine and drug delivery.

Latest Patents

Ishiguro's latest patents focus on cell penetrating peptides that possess the ability to penetrate cellular membranes. These patents include a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 1, as well as similar peptides with sequences of SEQ ID NO: 2 and SEQ ID NO: 3. Additionally, he has developed complexes that incorporate these peptides along with functional molecules, enhancing their utility in therapeutic applications.

Career Highlights

Throughout his career, Akira Ishiguro has worked with esteemed institutions such as The University of Tokyo and Astellas Pharma GmbH. His research has garnered attention for its innovative approach to overcoming cellular barriers, which is crucial for effective drug delivery systems.

Collaborations

Ishiguro has collaborated with notable colleagues in his field, including Yoshikazu Nakamura and Hideki Endo. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Akira Ishiguro's work in cell penetrating peptides exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for new therapeutic strategies that could revolutionize drug delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…